US3293133A - Method of imparting color to pharmaceutical solutions - Google Patents

Method of imparting color to pharmaceutical solutions Download PDF

Info

Publication number
US3293133A
US3293133A US275230A US27523063A US3293133A US 3293133 A US3293133 A US 3293133A US 275230 A US275230 A US 275230A US 27523063 A US27523063 A US 27523063A US 3293133 A US3293133 A US 3293133A
Authority
US
United States
Prior art keywords
aqueous pharmaceutical
coloring
solution
coloring material
color
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US275230A
Inventor
John A Hill
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Priority to US275230A priority Critical patent/US3293133A/en
Application granted granted Critical
Publication of US3293133A publication Critical patent/US3293133A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Definitions

  • This invention has as one of its objects the preparation of aqueous pharmaceutical solutions possessing uniform color characteristics, which color characteristics are not lost after storage for extended periods of time.
  • Another object of this invention is the application of a water insoluble coloring material to an aqueous pharmaceutical solution.
  • Still another object of this invention is the imparting of a color to a pharmaceutical solution by the employment of Food and Drug Administration approved coloring materials.
  • Yet another object of this invention is the imparting of a color to a pharmaceutical solution by the employment of an economical and efiicient method not heretofore known.
  • the coloring materials which may be employed in the practice of this invention are those which are substantially water insoluble and are certified for use in pharmaceutical compositions. More specifically, they include such dyes designated by their Food and Drug Administration designations as D & C Blue No. 6, D & C Blue No. 9, D & C Green No. 6, D & C Violet No. 2, D & C Red No. 17, D & C Red No. 19, D & C Red No.21, D & C Orange No. 5, D & C Yellow No. 7, D '& C Yellow No. 11, D & C RedNo. 6,D&CRedNo. 7, D&CRedNo. 35,D&C Orange No. 15, D & C Yellow No. 6, D & C Green No. 1, D & C Blue No. 1, D & C Violet No. 7, and other like coloring materials. Further exemplary are the substantially Water insoluble FD & C and D & C colors listed in the Merck Index, Sixth Edition.
  • the coloring material is first dissolved in an organic solvent and the resulting solution is deposited on the surface of a free-flowing particulate, water soluble material.
  • organic solvents which may be employed in the practice of this invention are those volatile solvents in Which the respective coloring material may be completely dissolved. They include such organic solvents as acetone, methanol, benzene, ethanol and other like volatile solvents. In the most preferable embodiment of this invention, acetone is employed, although the other solvents yield the same results.
  • the particulate water soluble material which may be employed in the practice of this invention, is one which is non-toxic, pharrnaceutically acceptable and is free-flowing and will absorb the water insoluble coloring material on the surface thereof and includes such materials as sugars, such as lactose, sucrose or dextrose; salts, such as sodium chloride, or potassium chloride; and hydrocolloids, such as acacia, guar gum, tragacanth, sodium carboxy methyl cellulose, gelatin and mannitol.
  • sugars such as lactose, sucrose or dextrose
  • salts such as sodium chloride, or potassium chloride
  • hydrocolloids such as acacia, guar gum, tragacanth, sodium carboxy methyl cellulose, gelatin and mannitol.
  • crystalline sucrose is employed.
  • the coloring material in the solution is deposited on the surface of the water soluble particulate material, the solvent is driven off yielding a substantially dry, coloring composition comprising a freely dispersible particulate water soluble material, having the substantially water insoluble coloring material intimately and uniformly adherent to the surfaces thereof.
  • This coloring composition may be employed directly and immediately in imparting a color to a pharmaceutical solution or it may be held in its substantially dry state for future use in the furtherance of the principles of this invention.
  • the coloring composition is employed to impart color to any aqueous pharmaceutical solution by its intimate dispersion into the pharmaceutical solution to be treated.
  • This intimate dispersion may be accomplished in any manner known to the art to accomplish such an objective, for example, by introducing the desired amount of substantially dry coloring composition into the aqueous pharmaceutical solution by vigorous mixing, as by treatment on a rotary shaker until a substantially uniform coloris obtained.
  • the amounts of the respective ingredients which may be employed in the practice of this invention are those which will impart a uniform color to an aqueous pharmaceutical solution. It has been found that the respective amount of the ingredients which may be used to produce the final products of this invention are from about 0.001% to about 1.0% by weight of the insoluble coloring material about 0.1% to about 20.0% of the water soluble particulate material and about 75.0% to about 99.9% of the aqueous pharmaceutical solution.
  • aqueous pharmaceutical solutions which may be employed in the practice of this invention include those solutions which possess antibiotic, steroidal and diuretic activity. Included in such aqueous pharmaceutical solutions are tetracycline compositions, amphotericin compositions, progestogen compositions, benzothiadiazine compositions and other like pharmaceutical preparations. In the most preferable embodiment of this invention the aqueous pharmaceutical product is one of antibiotic activity, such as tetracycline, although others may be employed with like results.
  • Example 1 Into 6.0 cc. of ace-tone there is dissolved 0.12 g. of D & C dye Red No. 21 with stirring. The resultant solution is then sprayed evenly over the surface of 25 g. of crystalline sucrose in a revolving pan until the entire surface of the sucrose has been colored by the solution. The acetone solvent is then driven off and the resultant dried colored sucrose is then dissolved in 1000 mi. of a 31% aque-.
  • a process for imparting a uniform color to an aqueous pharmaceutical solution which comprises (a) dissolving a water insoluble pharmaceutically acceptable non-toxic coloring material in an organic solvent;
  • a coloring composition for imparting a water insoluble color to an aqueous pharmaceutical solution which comprises a substantially free-flowing, non-toxic, pharmaceutically acceptable water somluble particulate material selected from the group consisting of sugars, salts and hydrocolloids having a water insoluble coloring material adherent to the surfaces thereof.
  • a process for imparting a uniform color to an aqueous pharmaceutical solution which comprises:
  • organic solvent is selected from the group consisting of acetone, methanol, ethanol, and benzene.
  • particulate material is selected from the group consisting of lactose, sucrose, dextrose, sodium chloride, potassium chloride, acacia, guar gum, tragacanth, sodium carboxyrnethylcellulose, gelatin and mannitol.
  • composition in accordance with claim 2 wherein the particulate material is sucrose.
  • composition in accordance with claim 6 wherein the water-insoluble coloring material is D & C No. 21.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)

Description

United States Patent 3,293,133 METHOD OF IMPARTING COLOR TO PHARMA- CEUTICAL SOLUTIONS John A. Hill, New Brunswick, N.J., assignor to E. R. Squibb & Sons Inc., New York, N.Y., a corporation of Delaware N0 Drawing. Filed Apr. 24, 1963, Ser. No. 275,230 7 Claims. (Cl. 16782) This invention relates to new coloring compositions and to novel processes for imparting a color to a pharmaceutical solution. More particularly, this invention relates to methods for applying water insoluble colors to aqueous pharmaceutical preparations and the new coloring compositions employed therefor.
Heretofore, it has been possible to color an aqueous pharmaceutical solution only by employing exceedingly large quantities of the water insoluble coloring material and the results obtained have not been uniformly satisfactory. It was found that a water insoluble coloring material, when applied to an aqueous pharmaceutical solution, behaves like a pigment, and exceedinly large quantities must be used to impart a color thereto. After these large quantities of coloring material are employed, the color of the resultant pharmaceutical composition was unsatisfactory, as the insoluble coloring material settled out in substantial amounts, even after only short periods of storage.
A great number of coloring materials which may otherwise be satisfactorily employed for the purposes here desired may not be used in pharmaceutical compositions as their use is forbidden or limited by the Food and Drug Administration.
This invention has as one of its objects the preparation of aqueous pharmaceutical solutions possessing uniform color characteristics, which color characteristics are not lost after storage for extended periods of time.
Another object of this invention is the application of a water insoluble coloring material to an aqueous pharmaceutical solution.
Still another object of this invention is the imparting of a color to a pharmaceutical solution by the employment of Food and Drug Administration approved coloring materials.
Yet another object of this invention is the imparting of a color to a pharmaceutical solution by the employment of an economical and efiicient method not heretofore known.
Still other objects of this invention will become apparent from a further reading of this specification.
The coloring materials, which may be employed in the practice of this invention are those which are substantially water insoluble and are certified for use in pharmaceutical compositions. More specifically, they include such dyes designated by their Food and Drug Administration designations as D & C Blue No. 6, D & C Blue No. 9, D & C Green No. 6, D & C Violet No. 2, D & C Red No. 17, D & C Red No. 19, D & C Red No.21, D & C Orange No. 5, D & C Yellow No. 7, D '& C Yellow No. 11, D & C RedNo. 6,D&CRedNo. 7, D&CRedNo. 35,D&C Orange No. 15, D & C Yellow No. 6, D & C Green No. 1, D & C Blue No. 1, D & C Violet No. 7, and other like coloring materials. Further exemplary are the substantially Water insoluble FD & C and D & C colors listed in the Merck Index, Sixth Edition.
It has now been found that a uniform color, which is retained by the aqueous pharmaceutical solution, even after extended periods, may be produced by the employment of 'a water insoluble coloring material. According to the novel process of this invention, the coloring material is first dissolved in an organic solvent and the resulting solution is deposited on the surface of a free-flowing particulate, water soluble material.
The organic solvents which may be employed in the practice of this invention are those volatile solvents in Which the respective coloring material may be completely dissolved. They include such organic solvents as acetone, methanol, benzene, ethanol and other like volatile solvents. In the most preferable embodiment of this invention, acetone is employed, although the other solvents yield the same results. The particulate water soluble material which may be employed in the practice of this invention, is one which is non-toxic, pharrnaceutically acceptable and is free-flowing and will absorb the water insoluble coloring material on the surface thereof and includes such materials as sugars, such as lactose, sucrose or dextrose; salts, such as sodium chloride, or potassium chloride; and hydrocolloids, such as acacia, guar gum, tragacanth, sodium carboxy methyl cellulose, gelatin and mannitol.
In the most preferable embodiment of the invention, crystalline sucrose is employed. The coloring material in the solution is deposited on the surface of the water soluble particulate material, the solvent is driven off yielding a substantially dry, coloring composition comprising a freely dispersible particulate water soluble material, having the substantially water insoluble coloring material intimately and uniformly adherent to the surfaces thereof. This coloring composition may be employed directly and immediately in imparting a color to a pharmaceutical solution or it may be held in its substantially dry state for future use in the furtherance of the principles of this invention.
The coloring composition is employed to impart color to any aqueous pharmaceutical solution by its intimate dispersion into the pharmaceutical solution to be treated. This intimate dispersion may be accomplished in any manner known to the art to accomplish such an objective, for example, by introducing the desired amount of substantially dry coloring composition into the aqueous pharmaceutical solution by vigorous mixing, as by treatment on a rotary shaker until a substantially uniform coloris obtained.
The amounts of the respective ingredients which may be employed in the practice of this invention are those which will impart a uniform color to an aqueous pharmaceutical solution. It has been found that the respective amount of the ingredients which may be used to produce the final products of this invention are from about 0.001% to about 1.0% by weight of the insoluble coloring material about 0.1% to about 20.0% of the water soluble particulate material and about 75.0% to about 99.9% of the aqueous pharmaceutical solution.
The aqueous pharmaceutical solutions which may be employed in the practice of this invention include those solutions which possess antibiotic, steroidal and diuretic activity. Included in such aqueous pharmaceutical solutions are tetracycline compositions, amphotericin compositions, progestogen compositions, benzothiadiazine compositions and other like pharmaceutical preparations. In the most preferable embodiment of this invention the aqueous pharmaceutical product is one of antibiotic activity, such as tetracycline, although others may be employed with like results.
The following example is illustrative of the invention:
Example 1 Into 6.0 cc. of ace-tone there is dissolved 0.12 g. of D & C dye Red No. 21 with stirring. The resultant solution is then sprayed evenly over the surface of 25 g. of crystalline sucrose in a revolving pan until the entire surface of the sucrose has been colored by the solution. The acetone solvent is then driven off and the resultant dried colored sucrose is then dissolved in 1000 mi. of a 31% aque-.
ous suspension of tetracycline with vigorous mixing to yield a substantially evenly colored aqueous suspension of tetracycline.
Similarly, if equivalent amounts of aqueous pharmaceutical solutions of such pharmaceuticals as tetracycline, dimethyltetracycline, amphotericin etc. are substituted for tetracycline, like results are obtained.
, The invention may be variously otherwise embodied within the scope of the appended claims. What is claimed is:
1. A process for imparting a uniform color to an aqueous pharmaceutical solution which comprises (a) dissolving a water insoluble pharmaceutically acceptable non-toxic coloring material in an organic solvent;
(b) dispersing the said coloring material over the surface of a Water soluble pharmaceutically acceptable free-flowing particulate material selected from the group consisting of sugars, salts and hydrocolloids by contacting said particulate material with the said colored organic solution;
(c) removing the said organic solvent to obtain a substantially dry coloring composition comprising particulate material having adherent to the surfaces thereof the said insoluble coloring material; and
(d) intimately introducing into an aqueous pharmaceutical product the said coloring composition to obtain a uniformly colored aqueous pharmaceutical solution.
2. A coloring composition for imparting a water insoluble color to an aqueous pharmaceutical solution which comprises a substantially free-flowing, non-toxic, pharmaceutically acceptable water somluble particulate material selected from the group consisting of sugars, salts and hydrocolloids having a water insoluble coloring material adherent to the surfaces thereof.
3. A process for imparting a uniform color to an aqueous pharmaceutical solution which comprises:
(a) dissolving a water-insoluble pharmaceutically acceptable non-toxic coloring material in an organic solvent;
(b) dispersing the coloring material over the surface of a water-soluble pharmaceutically acceptable freeflowing crystalline sucrose material by contacting said material with the colored organic solution;
(0) removing the said organic solvent to obtain a substantially dried coloring composition comprising particulate sucrose having adherent to the surfaces thereof the said insoluble material;
(d) intermittently introducing into an aqueous pharmaceutical product the said coloring composition to obtain a uniformly colored aqueous pharmaceutical solution.
4. A process in accordance with the process of claim 1 wherein the organic solvent is selected from the group consisting of acetone, methanol, ethanol, and benzene.
5. A process in accordance with the process of claim 1 wherein the particulate material is selected from the group consisting of lactose, sucrose, dextrose, sodium chloride, potassium chloride, acacia, guar gum, tragacanth, sodium carboxyrnethylcellulose, gelatin and mannitol.
6. A composition in accordance with claim 2 wherein the particulate material is sucrose.
7. A composition in accordance with claim 6 wherein the water-insoluble coloring material is D & C No. 21.
References Cited by the Examiner UNITED STATES PATENTS 2,553,617 5/1951 Wendt 99-148 2,610,917 9/1952 Hensgen 99l48 2,693,436 11/ 1954 Spradling l6782 2,841,499 7/ 1958 Grossi 99148 2,925,365 2/ 1960 Nicholson et a1. 16-782 3,028,307 4/1962 Ninger 16782 3,054,724 9/1962 Raff 16782 3,079,303 2/1963 Raff et a1. 16782 3,105,008 9/ 1963 Kaplan et al 16782 3,200,039 8/1965 Thompson 16'782 FOREIGN PATENTS 269,796 4/ 1927 Great Britain.
JULIAN S. LEVITI, Primary Examiner.
FRANK CACC-IAPAGLIA, 1a., Examiner.
GEORGE A. MENTIS, Assistant Examiner.

Claims (1)

1. A PROCESS FOR IMPARTING A UNIFORM COLOR TO AN AQUEOUS PHARMACEUTICAL SOLUTION WHICH COMPRISES (A) DISSOLVING A WATER INSOLUBLE PHARMACEUTICALLY ACCEPTABLE NON-TOXIC COLORING MATERIAL IN AN ORGANIC SOLVENT; (B) DISPERSING THE SAID COLORING MATERIAL OVER THE SURFACE OF A WATER SOLUBLE PHARMACEUTICALLY ACCEPTABLE FREE-FLOWING PARTICULATE MATERIAL SELECTED FROM THE GROUP CONSISTING OF SUGARS, SALTS AND HYDROCOLLOIDS BY CONTACTING SAID PARTICULATE MATERIAL WITH THE SAID COLORED ORGANIC SOLUTION; (C) REMOVING THE SAID ORGANIC SOLVENT TO OBTAIN A SUBSTANTIALLY DRY COLORING COMPOSITION COMPRISING PARTICULATE MATERIAL HAVING ADHERENT TO THE SURFACES THEREOF THE SAID INSOLUBLE COLORING MATERIAL; AND (D) INTIMATELY INTRODUCING INTO AN AQUEOUS PHARMACEUTICAL PRODUCT THE SAID COLORING COMPOSITION TO OBTAIN A UNIFORMLY COLORED AQUEOUS PHARMACEUTICAL SOLUTION.
US275230A 1963-04-24 1963-04-24 Method of imparting color to pharmaceutical solutions Expired - Lifetime US3293133A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US275230A US3293133A (en) 1963-04-24 1963-04-24 Method of imparting color to pharmaceutical solutions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US275230A US3293133A (en) 1963-04-24 1963-04-24 Method of imparting color to pharmaceutical solutions

Publications (1)

Publication Number Publication Date
US3293133A true US3293133A (en) 1966-12-20

Family

ID=23051408

Family Applications (1)

Application Number Title Priority Date Filing Date
US275230A Expired - Lifetime US3293133A (en) 1963-04-24 1963-04-24 Method of imparting color to pharmaceutical solutions

Country Status (1)

Country Link
US (1) US3293133A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3619294A (en) * 1968-07-15 1971-11-09 Penick & Ford Ltd Method of combining crystalline sugar with impregnating agents and products produced thereby
JPS5029733A (en) * 1973-07-18 1975-03-25
JPS50101517A (en) * 1974-01-22 1975-08-12
US4029782A (en) * 1975-04-28 1977-06-14 Eli Lilly And Company Cefazolin suspension for parenteral administration
US4537637A (en) * 1980-08-19 1985-08-27 The Coca-Cola Company Hydration drying process
US8357417B2 (en) 2010-03-31 2013-01-22 Purecircle Sdn Bhd Low calorie composite sweetener as sugar alternative and methods for producing the same

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB269796A (en) * 1926-10-12 1927-04-28 Alfred Owen Morris Improvements in or connected with the manufacture of tinted or coloured pulverulent substances
US2553617A (en) * 1946-03-07 1951-05-22 Fred Fear & Company Coloring composition capable of forming a film on water
US2610917A (en) * 1949-05-21 1952-09-16 Swift & Co Coloring agent for plastic materials
US2693436A (en) * 1951-02-27 1954-11-02 Upjohn Co Coating material for tablets and coated tablets
US2841499A (en) * 1955-03-03 1958-07-01 Union Starch & Refining Compan Colored food product and method of making the same
US2925365A (en) * 1957-11-27 1960-02-16 Smith Kline French Lab Coloring solid pharmaceutical forms and compositions therefor
US3028307A (en) * 1959-05-27 1962-04-03 Warner Lambert Pharmaceutical Pre-dried granulation and production of sublingual compressed organic nitrate tablets with selected solubilizing agents
US3054724A (en) * 1960-05-12 1962-09-18 Smith Kline French Lab Coloring discrete solids and compositions therefor
US3079303A (en) * 1958-12-11 1963-02-26 Smith Kline French Lab Basic tablet granulation and process of using same
US3105008A (en) * 1958-03-20 1963-09-24 Bristol Myers Co Tetracycline formulations
US3200039A (en) * 1962-05-28 1965-08-10 Pfizer & Co C Non-granulated tablets with 20% sorbitol in a particle size of from about 100mu to about 2000mu

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB269796A (en) * 1926-10-12 1927-04-28 Alfred Owen Morris Improvements in or connected with the manufacture of tinted or coloured pulverulent substances
US2553617A (en) * 1946-03-07 1951-05-22 Fred Fear & Company Coloring composition capable of forming a film on water
US2610917A (en) * 1949-05-21 1952-09-16 Swift & Co Coloring agent for plastic materials
US2693436A (en) * 1951-02-27 1954-11-02 Upjohn Co Coating material for tablets and coated tablets
US2841499A (en) * 1955-03-03 1958-07-01 Union Starch & Refining Compan Colored food product and method of making the same
US2925365A (en) * 1957-11-27 1960-02-16 Smith Kline French Lab Coloring solid pharmaceutical forms and compositions therefor
US3105008A (en) * 1958-03-20 1963-09-24 Bristol Myers Co Tetracycline formulations
US3079303A (en) * 1958-12-11 1963-02-26 Smith Kline French Lab Basic tablet granulation and process of using same
US3028307A (en) * 1959-05-27 1962-04-03 Warner Lambert Pharmaceutical Pre-dried granulation and production of sublingual compressed organic nitrate tablets with selected solubilizing agents
US3054724A (en) * 1960-05-12 1962-09-18 Smith Kline French Lab Coloring discrete solids and compositions therefor
US3200039A (en) * 1962-05-28 1965-08-10 Pfizer & Co C Non-granulated tablets with 20% sorbitol in a particle size of from about 100mu to about 2000mu

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3619294A (en) * 1968-07-15 1971-11-09 Penick & Ford Ltd Method of combining crystalline sugar with impregnating agents and products produced thereby
JPS5029733A (en) * 1973-07-18 1975-03-25
JPS5812259B2 (en) * 1973-07-18 1983-03-07 ワコウジユンヤクコウギヨウ カブシキガイシヤ Chiyakushiyokusareta Himakkei Seiyousoseibutsu
JPS50101517A (en) * 1974-01-22 1975-08-12
US4029782A (en) * 1975-04-28 1977-06-14 Eli Lilly And Company Cefazolin suspension for parenteral administration
US4537637A (en) * 1980-08-19 1985-08-27 The Coca-Cola Company Hydration drying process
US8357417B2 (en) 2010-03-31 2013-01-22 Purecircle Sdn Bhd Low calorie composite sweetener as sugar alternative and methods for producing the same
US8591980B2 (en) 2010-03-31 2013-11-26 Purecircle Sdn Bhd Low calorie composite sweetener as sugar alternative and methods for producing the same

Similar Documents

Publication Publication Date Title
DE69219303T2 (en) Film coatings and coating compositions based on cellulose polymers and lactose
US3054724A (en) Coloring discrete solids and compositions therefor
DE69102270T3 (en) Film forming product for coating solids.
US3185626A (en) Tablet coating method
DE69121098T2 (en) AQUEOUS FILM-FORMING COATING COMPOSITIONS MALTODEXTRIN AND CELLULOSE DERIVATIVES
DE69724585T2 (en) WATER-DISPERSIBLE COMPOSITIONS CONTAINING A NATURAL, HYDROPHILIC PIGMENT, METHOD FOR THEIR PRODUCTION AND THEIR USE
IL23149A (en) Dragee and process for the production of dragees
US4274830A (en) Colored medicinal tablet, natural color pigment and method for using the pigment in coloring food, drug and cosmetic products
US3097144A (en) Heat-cured, polymeric, medicinal dosage film coatings containing a polyvinylpyrrolidone copolymer, polyethenoid acid, and polyethylene glycol
US2925365A (en) Coloring solid pharmaceutical forms and compositions therefor
US3293133A (en) Method of imparting color to pharmaceutical solutions
US3802896A (en) Color concentrated base dispersion used in tablet film coating
DE1492156B2 (en) Use of water-soluble shellac for coating solid medicinal preparations for oral administration
DE2854651C2 (en)
DE2058163A1 (en) Method for coating tablets
DE3229876A1 (en) GRANULATED MIXED PREPARATION MADE OF SPHERICAL GRAINS WITH LONG-TERM EFFECT
US3692768A (en) Nacreous pigments from nucleic acid derivatives
DE2522483C2 (en) Process for the production of coated tablets
JPH093348A (en) Method for preventing discoloration of colorant, and colorant composition
US2949402A (en) Tablet coating
DE69104836T2 (en) GELATINE-COVERED MEDICINAL PRODUCTS AND METHOD FOR THE PRODUCTION THEREOF.
GB1174140A (en) Improvements in or relating to the Colour-Coating of Whole in-Shell Nuts
NO179504B (en) Drug in the form of a tablet containing dirithromycin
US2163043A (en) Hair dyeing composition and method
US2116521A (en) Hair dyeing method and composition